Reply: Seroprevalence of SARS-CoV-2 After the Largest Initial Epidemic Wave in the United States: Findings from New York City, May 13-July 21, 2020

Affiliations

¹ Division of Global Health Equity, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
² Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

Comment

Lao-Tzu Allan-Blitz et al. J Infect Dis. 2021.

. 2021 Aug 2;224(3):556-557.

doi: 10.1093/infdis/jiab245.

¹ Division of Global Health Equity, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
² Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

No abstract available

Comment on

Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Following the Largest Initial Epidemic Wave in the United States: Findings From New York City, 13 May to 21 July 2020.
Pathela P, Crawley A, Weiss D, Maldin B, Cornell J, Purdin J, Schumacher PK, Marovich S, Li J, Daskalakis D; NYC Serosurvey Team. Pathela P, et al. J Infect Dis. 2021 Jul 15;224(2):196-206. doi: 10.1093/infdis/jiab200. J Infect Dis. 2021. PMID: 33836067 Free PMC article.